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Background: Transcatheter aortic valve implantation (TAVI) has recently emerged as a promising alternative
to surgical aortic valve replacement (AVR) in those patients whose surgical risk profile prevents them from
undergoing an open-heart procedure. However, TAVI is not without drawbacks and potential complications.
Peri-prosthetic aortic regurgitation (periAR) is a known complication of TAVI. Furthermore, moderate and
severe periAR have previously been identified as independent risk factors for short- and midterm mortality
following TAVI. Currently, there is very little information regarding long-term mortality in the presence of
periAR following TAVI.
Method: An exhaustive search of available medical literature was conducted by searching Medline-OVID,
CINAHL, Web of Science, and MDConsult using the terms: long-term outcomes, transcatheter aortic valve
implantation, and aortic regurgitation. Further, citations from articles were searched for additional pertinent
studies. Relevant articles were assessed for quality using GRADE. Articles with primary data regarding long-
term outcomes for patients with periAR following TAVI were included.
Results: Two studies met inclusion criteria and were evaluated in this systematic review. One retrospective
observational study with 202 patients identified moderate/severe periAR as the strongest independent risk
factor of both all-cause and cardiovascular mortality at 1-year. Another retrospective observational study with
146 participants concluded that AR index/or moderate/severe degree of periAR independently predicted
1-year mortality.
Conclusion: Degree of periAR and AR index both independently predict 1-year mortality following TAVI.
Assessment of periAR provides additional data that can be used to more accurately determine prognosis
following TAV
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Abstract   
 
Background:  Transcatheter aortic valve implantation (TAVI) has recently emerged as a 
promising alternative to surgical aortic valve replacement (AVR) in those patients whose 
surgical risk profile prevents them from undergoing an open-heart procedure. However, 
TAVI is not without drawbacks and potential complications. Peri-prosthetic aortic 
regurgitation (periAR) is a known complication of TAVI. Furthermore, moderate and 
severe periAR have previously been identified as independent risk factors for short- and 
midterm mortality following TAVI. Currently, there is very little information regarding 
long-term mortality in the presence of periAR following TAVI. 
Method: An exhaustive search of available medical literature was conducted by 
searching Medline-OVID, CINAHL, Web of Science, and MDConsult using the terms: 
long-term outcomes, transcatheter aortic valve implantation, and aortic regurgitation. 
Further, citations from articles were searched for additional pertinent studies. Relevant 
articles were assessed for quality using GRADE. Articles with primary data regarding 
long-term outcomes for patients with periAR following TAVI were included.  
Results:  Two studies met inclusion criteria and were evaluated in this systematic review. 
One retrospective observational study with 202 patients identified moderate/severe 
periAR as the strongest independent risk factor of both all-cause and cardiovascular 
mortality at 1-year. Another retrospective observational study with 146 participants 
concluded that AR index <25 and/or moderate/severe degree of periAR independently 
predicted 1-year mortality. 
Conclusion:  Degree of periAR and AR index both independently predict 1-year 
mortality following TAVI. Assessment of periAR provides additional data that can be 
used to more accurately determine prognosis following TAVI. 
 
Keywords:  long-term outcomes, transcatheter aortic valve implantation, aortic 
regurgitation 
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Degree of Peri-Prosthetic Aortic Regurgitation: An Independent 
Predictor of Long-Term Mortality Following Transcatheter Aortic 
Valve Replacement 
 
BACKGROUND 
Symptomatic aortic stenosis (AS) carries a very poor prognosis.1,2 On average, 
survival is not more than two to three years following development of symptoms. 
Consequently, onset of symptomatic AS is an indication for valve replacement.3 While no 
randomized controlled studies have been conducted to date, observational studies have 
consistently found that corrective surgery in the setting of symptomatic AS is typically 
followed by improvement of symptoms and decreased mortality when compared with 
medical management alone.4  
Surgical aortic valve replacement (AVR) is widely considered the current gold 
standard for treatment of AS.5 For those patients considered healthy enough for AVR, 
overall operative risk is low and the procedure yields substantial relief of symptoms as 
well as improved overall life expectancy. However, surgical AVR carries increased 
operative risk for some patients including those with concomitant coronary artery disease 
(CAD), the elderly, patients considered medically frail, those with severely reduced left 
ventricular (LV) function, or patients with significant comorbidities such as cerebral and 
peripheral vascular disease, renal failure, and respiratory dysfunction.5,6 
Transcatheter aortic valve implantation (TAVI) was introduced in 2002 as a 
promising alternative to surgical AVR for those patients considered at high surgical risk, 
however TAVI has some limitations, particularly because it is a very new procedure.7 
 8 
The PARTNER (Placement of AoRTic TraNscathetER Valve) trial8-13 demonstrated that 
TAVI is associated with similar 30-day and 1-year mortality in high-risk patients when 
compared with AVR. However, it also identified some clinically important drawbacks, 
most importantly, risk of moderate and severe peri-prosthetic aortic regurgitation 
(periAR), which recent studies estimate a prevalence of approximately 15% to 20%.8-13 In 
fact, moderate to severe periAR has been identified as an independent risk factor for short 
and midterm mortality following TAVI.9,13-16 Unfortunately, there is currently very little 
data available regarding long-term (>1 year) outcomes related to post-procedure AR.  
METHODS 
An exhaustive search of available medical literature was conducted by searching 
Medline-OVID, CINAHL, Web of Science, and MDConsult using the terms: long-term 
outcomes, transcatheter aortic valve implantation, and aortic regurgitation. Further, 
citations from articles were searched for additional pertinent studies. Articles with 
primary data regarding long-term outcomes for patients with periAR following TAVI 
were included. Relevant articles were assessed for quality using the Grading of 
Recommendations, Assessment, Development, and Evaluation (GRADE) scale.17  
RESULTS 
Initial search results yielded five potential articles for review. Following 
screening of articles for relevance, two studies16,18 met inclusion criteria. Both studies are 
retrospective observational studies. Three additional studies9,14,19 were excluded because 
they did not directly address long-term outcomes related specifically to periAR.  
Gotzmann et al 
 9 
This retrospective observational study18 investigated incidence of AR following 
TAVI with the CoreValve prosthesis (Medtronic CV, Minneapolis, Minnesota) along 
with its effect on functional status and long-term outcomes. Investigators enrolled 202 
consecutive patients with either native aortic stenosis or degenerated aortic bioprosthesis 
who underwent transfemoral (n=197) or transaxillary (n=4) TAVI. During 
echocardiographic examination following TAVI, patients were subdivided into two 
independently analyzed groups based on presence of no/mild or moderate/severe 
measured post-procedural AR. The primary study end point was all-cause mortality 
following TAVI. Secondary endpoint was cardiovascular death, which included death 
from myocardial infarction, stroke, sudden cardiac death, heart failure, fatal prosthesis 
failure with conversion to open heart surgery, and death from unknown cause. All study 
participants were followed for a minimum of one year, either during routine ambulatory 
visits, or via telephone conversations with the physicians of deceased patients.18  
Individual patient risk for surgical AVR was estimated using the logistic 
European System for Cardiac Operative Risk Evaluation (EuroSCORE). Prior to TAVI 
the aortic annulus of each patient was measured using either transthoracic or 
transesophageal echocardiography (TEE). Annulus dimensions were also measured using 
computed tomography (CT) in 154 of the 202 study participants. Based on pre-procedural 
measurements of aortic annulus, prosthesis size was determined by consensus of the 
interventional team. Patients were monitored for intra-procedural AR by supra-aortic 
angiography.20 Directly following TAVI, invasive measurements, including end-diastolic 
pressure, were taken for use during retrospective calculation of aortic regurgitation index 
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which is expressed as a ratio of ([diastolic blood pressure minus left ventricular end-
diastolic pressure]/system blood pressure).18 
Echocardiographic examinations were preformed within 7 days prior to TAVI, 
within 5 days following TAVI, at 30 days, at 12 months, then annually thereafter, to 
monitor for presence of post-procedural AR. Following TAVI, prosthetic AR was graded 
by echocardiography as mild, moderate, or severe according to Valve Academic 
Research Consortium (VARC) criteria21.18 
Of the 202 enrolled patients, three died prior to the procedure and two patients 
were converted to surgery due to severe post-procedure AR. As such, these five patients 
were not included in data analysis. Baseline characteristics of study patients and post-
procedure AR were evaluated for all-cause and cardiovascular mortality in univariate 
regression analysis. Variables identified as significantly associated with study endpoints 
were entered in multivariate regression analysis to identify independent predictors of all-
cause and cardiovascular mortality. Results are available as hazard ratios (HR) and 
outcomes were analyzed using Kaplan-Meier survival curves.18 
During post-procedural echocardiography 115 (58%) patients were identified as 
having some degree of AR. Aortic regurgitation was considered mild in 83 (43%), 
moderate in 24 (12%), and severe in 4 (2%) of these patients. Overall, all-cause mortality 
rates at 30-days and at one-year post-procedure were 9% and 22%, respectively. For 
patients in the moderate/severe AR subgroup 30-day and 1-year mortality rates were 
markedly higher at 21% and 57% respectively as opposed to the no/mild subgroup at 6% 
and 16% respectively. Total follow-up for the study was 535 ± 333 days during which the 
 11
primary study endpoint of all-cause mortality was reached by a total of 54 (26%) patients, 
16 of which occurred in the first 30 days, while 38 occurred after 30 days. The secondary 
endpoint of cardiovascular death was reached by a total of 33 (15%) patients; 9 during 
the first 30 days and 24 after 30 days.18 
Following stepwise multivariable analysis, moderate/severe AR, pre-procedural 
EuroSCORE, atrial fibrillation, and aortic mean gradient were all identified as 
independent risk factors for all-cause mortality. Of these independent risk factors, post-
procedure AR was found to be the strongest (HR 4.89, confidence interval (CI) 2.793 to 
8.557, p <0.001). Moreover, moderate/severe AR was identified as the strongest risk 
factor both for mortality during the first 30 days post-TAVI (HR 3.83, CI 1.384 to 
10.482, p = 0.010) and after 30 days (HR 5.48, CI 2.807 to 10.683, p <0.001).18 
Furthermore, stepwise multivariate analysis identified pre-procedural 
EuroSCORE, female gender, and moderate/severe AR as independent risk factors for 
cardiovascular death, with the latter again being the strongest (HR 7.90, 95% CI 3.95 to 
15.807, p <0.001). Likewise, moderate/severe AR was the strongest risk factor for 
cardiovascular mortality in the first 30 days following TAVI (HR 7.90, 95% CI 4.193-
21.27, p <0.001) as well as after 30 days (HR 9.44, 95% CI 4.193 to 21.27, p <0.001).18 
This study emphasizes that moderate/severe AR post-TAVI is a primary 
contributor to long-term all-cause and cardiovascular mortality. It also illustrates the 
profound impact that degree of post-procedure AR has for overall patient prognosis. 
Despite similar baseline characteristics, patients with moderate/severe AR had 
consistently worse outcomes when compared with those who had no/mild AR following 
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TAVI. This study suggests that post-procedure AR has an important impact on mortality, 
and therefore should be considered when evaluating a patient’s long-term prognosis 
following TAVI.18 
Sinning et al 
 In this retrospective observational study16 investigators sought to determine 
implications of AR index on overall survival following TAVI. The study included 146 
patients who underwent TAVI with third-generation CoreValve prosthesis (Medtronic, 
Minneapolis, Minnesota). The primary outcome of this study was all-cause mortality at 
one year. All enrolled patients were considered at high risk for open-heart surgery: 
defined as a mean Society of Thoracic Surgeons mortality score of 9.8 ± 7.3%, or a mean 
logistic European System for Cardiac Operative Risk Evaluation score of 30.2 ± 18%. 
Prior to TAVI aortic valve annulus was determined via TEE as well as by CT. TAVI was 
performed with biplane fluoroscopy under local anesthesia and was predominantly 
guided by angiographic control.16 
Patients were assessed by a blinded echocardiographer, who did not attend the 
TAVI procedure, for occurrence and degree of periAR via immediate post-procedural 
angiography and transthoracic or TEE up until 3 days following TAVI. Invasive pressure 
measurements were taken in the left ventricle and ascending aorta simultaneously, 
immediately following TAVI. Aortic regurgitation index was calculated using the 
following equation: [(Diastolic blood pressure-left ventricular end-diastolic blood 
pressure)/systolic blood pressure] x 100. This calculated AR index from just prior to the 
end of the TAVI procedure was used for data analysis.16  
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Investigators minimized the number of false positives and negatives by using a 
receiver-operating characteristic curve analysis as maximum sum of sensitivity and 
specificity to establish the cutoff value of AR index as an independent predictor of all-
cause mortality at one year. Kaplan-Meier survival curves were then generated to 
evaluate survival based on the presence of periAR, as well as on the measured AR index. 
The Association of AR index and severity of periAR with 1-year mortality was 
determined via multivariate Cox regression analysis.16 
 At day three following TAVI, 53 (36.3%) patients had no signs of periAR, 71 
(48.6) patients had only mild periAR, 18 (12.3%) patients had moderate periAR, and 4 
(2.7%) patients had severe periAR. Grading of periAR was defined using VARC 
criteria.21 Patients were then split into no/mild and moderate/severe periAR subgroups for 
further evaluation.16 
 Within the first 30 days following TAVI, 10 (6.8%) patients died, while 39 
(26.7%) died during the 1-year follow-up period. For patients with no/mild periAR the 1-
year mortality rate was 20.2% (25 of 124), whereas the moderate/severe periAR subgroup 
suffered a much higher mortality rate at 63.6% (14 of 22). During univariate regression 
analysis, moderate/severe periAR following TAVI was correlated with increased 1-year 
mortality (HR 3.9, 95% CI 2.0 to 7.5, p < 0.001). Furthermore, patients with an AR index 
<25 had markedly increased 1-year mortality when compared to patients with an AR 
index ≥ 25% (46.0% and 16.7% respectively p < 0.001). Multivariate regression analysis 
revealed that AR index was also an independent predictor of 1-year mortality (HR 2.9, 
95% CI 1.3 to 6.4, p = 0.009).16 
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DISCUSSION 
Both studies highlight the impact of periAR on overall long-term prognosis. 
Gotzmann et al18 illustrated that patients with moderate/severe periAR following TAVI 
have consistently higher 1-year all-cause and cardiovascular mortality rates. Sinning et 
al16 confirmed this finding while also establishing that patients with calculated AR index 
<25 have a similarly elevated overall mortality rate. Both studies emphasize the value of 
assessing periAR and/or calculating AR index as a prognostic tool. 
Both studies16,18 had several similar limitations. Both only addressed the 
CoreValve prosthesis, thus results may not be applicable to TAVI with other prostheses. 
Additionally, the quality of both studies16,18  is limited by small sample size and 
monocentric character. Furthermore, investigators from both studies16, 18 identified the 
specific limitations of their respective research. Sinning et al16 noted that CT has been 
previously established as the most accurate means by which to determine the correct 
annulus size, however CT was not used in 23% of study patients due to renal failure. In 
these patients annulus size was determined solely via echocardiography. Moreover, 
Gotzmann et al18 acknowledged the limitations of AR index as a prognostic tool in that it 
relies on left ventricular end diastolic pressure which may fluctuate due to many factors 
following TAVI, ultimately leading to false positive or negative AR indices. Thus, AR 
index should be considered of complementary value when assessing periAR and overall 
prognosis. 
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CONCLUSION 
 Aortic regurgitation index and degree of periAR have been identified as strong 
independent risk factors for long-term mortality following TAVI. Furthermore, patients 
with moderate to severe periAR consistently have worse outcomes and higher overall 
mortality rates. Both studies suggest that periAR be considered as an important predictor 
of general prognosis following TAVI. The overall quality of both studies is moderate 
based on GRADE criteria, largely because they are both retrospective observational 
studies. However, because this research involves a surgical procedure a study of higher 
quality, such as a randomized controlled trial may not be feasible. Nevertheless, further 
studies are needed to assess possible predictors and/or causes of periAR, and thus how it 
might be minimized or prevented altogether. As this procedure becomes more common, 
larger, multicenter studies should be conducted in order to substantiate and further assess 
the results of the studies16,18 evaluated in this review. Given that TAVI has only been in 
practice since 2008 it is imperative that this procedure continue to be studied and refined 
as it is an important alternative to AVR.  
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Table I. Characteristics of Reviewed Studies and Summary of Findings 
 
 
 
 
 
 
 
 
Quality Assessment Summary of Findings 
 Downgrade Criteria  # of Patients Effect Quality Importance 
No. of 
Studies 
Design Limitations Indirectness Imprecision Inconsistency 
Publication 
bias likely 
Study Treatment (total) 
Mortality 
(# of patients) 
Hazard Ratio 
(95% CI) 
 
Moderate 
 
Critical 
All-Cause Mortality 
Gotzmann et 
al 
202 55 
5.48 (2.807-
10.683) 
 
2 
 
2 Observational Limitations 
No serious 
indirectness 
No Serious 
imprecision 
No serious 
inconsistencies 
No bias 
likely 
Sinning et al 146 39 3.9 (2.0-7.5) 
Moderate Critical 
Cardiovascular Death 
1 1 Observational Limitations 
No serious 
indirectness 
No serious 
imprecision 
No serious 
inconsistencies 
No bias 
likely 
Gotzmann et 
al 
202 33 
9.44 (4.193- 
21.27) 
Moderate Critical 
